InvestorsHub Logo
Followers 0
Posts 136
Boards Moderated 0
Alias Born 02/28/2017

Re: pennystocKING13 post# 54493

Sunday, 04/23/2017 2:29:18 PM

Sunday, April 23, 2017 2:29:18 PM

Post# of 106837
Big pharmacy generic stem cells vs RMAT

In my opinion this is what is going on in the back ground.

Doctors who just want to use a patients stem cells for treatment do not want stem cells treated as a drug by the FDA. (USRM types)

Mesoblast is big pharma with their generic line and does not want individual stem cell use to succeed. They are aligned with Harvard, big investors like merril lynch and goldman sacs, and the big institutions that like expensive double blind trials.

RMAT will hopefully bypass a lot of the burocratic non sense in a sane effective way. There is a lot of the established heath industry threatened by it.

Have to see how this all plays out. Looks like this is a front row seat.